SYNTHESIS, SCREENING OF NOVEL 1-SUBSTITUTED-3-(4-OX O-2-PHENYLQUINAZOLIN- 3(4H)-YL) UREA AND THIOUREA ANALOGUES AS POTENT ANT IBACTERIALS
- Vol.11(11)
- M P Innovare Academic Sciences Pvt Ltd 2019
- 38-42p.
Objective: The proposed study is an attempt to determine antib acterial activity of synthesized novel 1-substitute d-3-(4-oxo-2-phenylquinazolin- 3(4H)-yl) urea and thiourea analogues as potent anti bacterials against S. aureus and E. coli bacteria. Methods: The present study reports new series of 1-substitut ed-3-(4-oxo-2-phenylquinazolin-3(4H)-yl) urea and t hiourea derivatives as potent antibacterial agents. Reagents used in the present study were of synthetic grade and solvents were use d after distillation. Novel quinazolinone analogues were synthesized by considering substitut ion pattern, characterization of the synthesized an alogues was performed using various techniques like Thin layer chromatography, Melting point, Infrared spectroscopy, Proton NMR spectromet ry and Mass spectrometry. TLC of the synthesized analogues was carried out by using (tol uene: methanol in the ratio 2:1), melting point was found by open capillary method, IR spectrum was recorded on JASCO V-530, 1H NMR was recorded on Bruker Avance Spectrometer and Mass spectra were ob tained from G6460A, triple quadrupole/MS/MS system. In vitro antibacterial activity was performed against S. aureus and E. coli. Results: Six derivatives of quinazolinone analogues were syn thesized. The structures of 1-substituted-3-(4-oxo- 2-phenylquinazolin-3(4H)-yl) urea and thiourea derivatives were confirmed by physical and spectral analysis. Synthesized molecules showe d Rf of 0.45-0.80 in toluene: methanol mobile phase, melting point was carried out by open capillary method and were in range of 90-210 ° C, IR spectrum was recorded in range of 14000-400 cm -1 and showed characteristic peaks of NH and of C-O-NH, 1H NMR of the compounds was distinct to confirm st ructures with delta values in the range of 7.53-11.960, Mass spectra pr oved parent peaks of synthesized compounds confirmi ng molecular weight. The compounds were assayed for antibacterial activity against S. aureus and E. coli using ciprofloxacin as standard. The synthesized an alogues have shown good yield and comparable antibacterial